Study Preview
Study Title and Description
Transobturator vs single-incision suburethral mini-slings for treatment of female stress urinary incontinence: early postoperative pain and 3-year follow-up
Key Questions Addressed
2 | Sling Adverse Events |
Primary Publication Information
Title | Transobturator vs single-incision suburethral mini-slings for treatment of female stress urinary incontinence: early postoperative pain and 3-year follow-up |
Author | Neuman M, Sosnovski V, Kais M, Ophir E, Bornstein J. |
Country | Department of Obstetrics and Gynecology, Western Galilee Hospital, Nahariya, Israel. mneuman@netvision.net.il |
Year | 2011 |
Numbers |
Pubmed ID: 22024263 1034 (internal) |
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Sling Adverse Events
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | Transobturator synthetic | TVT-O | |
2 | Minisling obturator | TVT-SECUR |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Study Type | Prospective nonrandom (2+ slings analyzed separately) | ||
Study Name | Three-Year Follow-up of Urethral Sling Operations | ||
Study Country ... | Other ... | Israel | |
Sling Category | Obturator synthetic | ||
Minisling H (obturator) | |||
Multicenter? | No | ||
Institution Type | Academic hospital | ||
Community hospital | |||
No. of Surgeons Performing the Procedures | 1 | ||
Surgeons' Training | Not reported | ||
Residents or Fellows Performing the Surgery? | Unclear/Not reported | ||
Adverse Event Ascertainment | Active | ||
Passive | |||
Was the Clavien-Dindo Classification of Surgical Complications system used? | No / Not reported | ||
Was a data safety monitoring board used? | No / Not reported | ||
Study Sponsor/Funding ... | Other ... | Funding not reported. Of note, paper specifically states that the authors have no financial disclosures, but 2008 Neuman paper stated that Neuman was a TVT-Secur trainer for Ethicon | |
Comments (overall study) | Study did list most relevant AEs; was not clear how all were assessed and follow up time for AEs was not clear. Subjects had not been included in previous publications. Patients were informed about both techniques, and the patient allowed to choose which arm they would be enrolled in. |
Results & Comparisons
No Results found.
Adverse Events
Arm or Total | Title | Description | Follow-up time | In-hospital or After discharge | Is event serious? | Reported definition of serious event | Number affected | Number at risk (analyzed) | Difference between 2 slings (eg, OR/RR or %, with 95% CI) | Reported P value between slings | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
Transobturator synthetic | Organ injury in OR (urethra, bladder, bowel) | in OR | in hospital | not listed | not listed | 0 | 73 | not listed | n/a | ||
Minisling obturator | 0 | 79 | |||||||||
Total | |||||||||||
Transobturator synthetic | EBL >100cc | in OR | in hospital | not listed | not listed | 0 | 73 | not listed | 4.80 | ||
Minisling obturator | 1 | 79 | |||||||||
Total | |||||||||||
Transobturator synthetic | Mesh erosion/extrusion/exposure/granulation tissue | not further defined | not listed | not listed | not listed | not listed | 1 | 73 | not listed | 1.00 | |
Minisling obturator | 0 | 79 | |||||||||
Total | |||||||||||
Transobturator synthetic | Infection, surgical site/wound | not further defined | not listed | not listed | not listed | not listed | 0 | 73 | not listed | n/a | |
Minisling obturator | 0 | 79 | |||||||||
Total | |||||||||||
Transobturator synthetic | "early voiding difficulty" | not further defined | not listed | not listed | not listed | not listed | 4 | 73 | not listed | 0.15 | |
Minisling obturator | 9 | 79 | |||||||||
Total | |||||||||||
Transobturator synthetic | Infection, UTI | not listed | not listed | not listed | not listed | 1 | 73 | not listed | 0.99 | ||
Minisling obturator | 1 | 79 | not listed | ||||||||
Total | |||||||||||
Transobturator synthetic | Pain, other (new or different after surgery) | early post operative vaginal pain, VAS higher than 3 | not listed | not listed | not listed | not listed | 22 | 60 | not listed | <0.001 | |
Minisling obturator | 1 | 77 | not listed | ||||||||
Total | |||||||||||
Transobturator synthetic | Pain, groin (new or different after surgery) | VAS higher than 3, resolved by 2 weeks | 2 weeks post op | not listed | not listed | not listed | 22 | 60 | not listed | <0.001 | |
Minisling obturator | 0 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | Retention requiring surgery | not listed | after discharge | not listed | not listed | 2 | 60 | not listed | not listed | ||
Minisling obturator | 2 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | post operative nocturia | not listed | after discharge | not listed | not listed | 14 | 60 | not listed | 0.11 | ||
Minisling obturator | 4 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | post operative frequency | not listed | after discharge | not listed | not listed | 9 | 60 | not listed | 0.69 | ||
Minisling obturator | 12 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | post operative urgency | not listed | after discharge | not listed | not listed | 14 | 60 | not listed | 0.10 | ||
Minisling obturator | 12 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | dyspareunia | When related to tape, patients underwent office or OR tape removal | not listed | after discharge | not listed | not listed | 0 | 60 | not listed | 0.03 | |
Minisling obturator | 5 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | retention requiring CISC | not listed | 1 week post op | not listed | not listed | 6 | 60 | not listed | not listed | ||
Minisling obturator | 3 | 77 | |||||||||
Total | |||||||||||
Transobturator synthetic | Transfusion post-op | not listed | in hospital | yes | not defined | 0 | 73 | not listed | not listed | ||
Minisling obturator | 0 | 79 | |||||||||
Total | |||||||||||
Transobturator synthetic | |||||||||||
Minisling obturator | |||||||||||
Total |